A post-hoc analysis of a randomized, double-blind, placebo-controlled, 12-week study of adult patients with major depression was done to assess remission
rates.
Remission was defined as HAM-D17 ≤7. P<0.0001 EFFEXOR XR vs. placebo. Average
daily dose was 111 mg for EFFEXOR XR.
